Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10312572" target="_blank" >RIV/00216208:11110/15:10312572 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/15:10312572 RIV/00216208:11160/15:10312572 RIV/61989592:15110/15:33156031 RIV/00179906:_____/15:10312572 RIV/00023728:_____/15:#0005003

Výsledek na webu

<a href="http://www.tandfonline.com/doi/full/10.3109/13697137.2014.995164" target="_blank" >http://www.tandfonline.com/doi/full/10.3109/13697137.2014.995164</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3109/13697137.2014.995164" target="_blank" >10.3109/13697137.2014.995164</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter

Popis výsledku v původním jazyce

Objectives Low adherence to treatment with bisphosphonates significantly impedes its effectiveness. The objectives were: (1) to compare adherence to oral weekly and monthly bisphosphonates with emphasis on dosing instructions; and (2) to study associations between adherence and beliefs about the bisphosphonate treatment among women >= 55 years. Methods A multicenter survey was performed in secondary-care patients with osteoporosis. Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS), questions on compliance with five dosing instructions and Beliefs about Medicines Questionnaire (BMQ) Specific were used. Results As many as 363 questionnaires (response rate 95%) were analyzed. Respondents (mean age 69 years) were treated with weekly bisphosphonates (37%) or monthly ibandronate (63%). Based on OS-MMAS, 67% of respondents showed high adherence with no differences between the subgroups. Only 44% of respondents were compliant with all dosing instructions. Compliance with dosin

Název v anglickém jazyce

Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter

Popis výsledku anglicky

Objectives Low adherence to treatment with bisphosphonates significantly impedes its effectiveness. The objectives were: (1) to compare adherence to oral weekly and monthly bisphosphonates with emphasis on dosing instructions; and (2) to study associations between adherence and beliefs about the bisphosphonate treatment among women >= 55 years. Methods A multicenter survey was performed in secondary-care patients with osteoporosis. Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS), questions on compliance with five dosing instructions and Beliefs about Medicines Questionnaire (BMQ) Specific were used. Results As many as 363 questionnaires (response rate 95%) were analyzed. Respondents (mean age 69 years) were treated with weekly bisphosphonates (37%) or monthly ibandronate (63%). Based on OS-MMAS, 67% of respondents showed high adherence with no differences between the subgroups. Only 44% of respondents were compliant with all dosing instructions. Compliance with dosin

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Climacteric

ISSN

1369-7137

e-ISSN

—

Svazek periodika

18

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

9

Strana od-do

608-616

Kód UT WoS článku

000359844900025

EID výsledku v databázi Scopus

2-s2.0-84932139663